Data as at IST. Index data may be delayed by up to 20 minutes. For real-time updates, kindly refer to the BSE and NSE websites.
Kilitch Drugs (India) Share Price
Know More₹307.00-13.00 (-4.06%)
04:01 PM, 12-Mar-2025BSE : 524500
NSE : KILITCH
Sector : Health care
ISIN Code : INE729D01010
- BSE
- 1D
- 5D
- 1M
- 6M
- 1Y
- 2Y
- 5Y
- MAX
Last Updated: 12-Mar-2025 | 04:01 PM IST
| Market Cap (₹ Cr) | 494 |
Traded Value (₹ Cr) | 0.02 |
Volume (Shares) | 518 |
Face Value (₹) | 10 |
52-Week High (₹) | 404.90 |
52-Week High Date | 12-Sep-2024 |
52-Week Low (₹) | 271.30 |
52-Week Low Date | 07-Apr-2025 |
All Time High (₹) | 469.85 |
All Time High Date | 08-Feb-2024 |
All Time Low (₹) | 0.75 |
All Time Low Date | 18-Mar-1998 |
Kilitch Drugs (India) Ltd
Market News
Kilitch Drugs Announcement
Kilitch Drugs (India) Ltd - Key Fundamentals
| PARAMETER | VALUES |
|---|---|
| Market Cap (₹ Cr) | 494 |
| EPS - TTM (₹) [C] | 12.13 |
| P/E Ratio (X) [C] | 25.31 |
| Face Value (₹) | 10 |
| Latest Dividend (%) | 5.00 |
| Latest Dividend Date | 20-Sep-2019 |
| Dividend Yield (%) | - |
| Book Value Share (₹) [C] | 117.72 |
| P/B Ratio (₹) [C] | 2.61 |
Funds Owning this Stock
| Scheme Name | Amount Invested (₹ Cr) | No Of Shares | Net Asset (%) |
|---|---|---|---|
| Data Not Found | |||
Research Reports
| Date | Broker | Action | Prices(₹) | Report |
|---|---|---|---|---|
| Data Not Found | ||||
Stock Strength
| Today's Low/High (₹) | 307.00 323.00 |
| Week Low/High (₹) | 146.75 323.00 |
| Month Low/High (₹) | 146.75 323.00 |
| Year Low/High (₹) | 271.30 405.00 |
| All time Low/High (₹) | 0.75 470.00 |
Share Price Returns
| Period | BSE | NSE | SENSEX | NIFTY |
|---|---|---|---|---|
| 1 Week | 104.05% | 143.76% | 22.97% | 27.64% |
| 1 Month | 100.98% | 141.45% | 19.03% | 23.24% |
| 3 Month | 74.38% | 112.18% | 19.93% | 24.47% |
| 6 Month | 89.21% | 129.38% | 25.04% | 29.23% |
| 1 Year | 40.76% | 68.75% | 24.11% | 27.96% |
| 3 Year | 154.14% | 207.24% | 82.98% | 91.93% |
Company Info
Company Information
Managing Director : Mukund P Mehta
Whole-time Director : Bhavin M Mehta
Independent Director : Hemang Engineer
Whole-time Director : Mira Bhavin Mehta
Independent Director : Murti Vasudev Krishna
Independent Director : Venkita Subramanian Rajan
Company Sec. & Compli. Officer : Pushpa Nyoupane
Registered Office: C-301/2 MIDC TTC Indl Area, Pawane Village,Thane,Maharashtra-400705 Ph: 91-022-27670322/27680913/65144185
Email:info@kilitch.com
FAQs about Kilitch Drugs (India) Ltd
1. What's the Kilitch Drugs (India) Ltd share price today?
Kilitch Drugs (India) Ltd share price was Rs 307.00 at 04:01 PM IST on 12th Mar 2025. Kilitch Drugs (India) Ltd share price was down by 4.06% from the previous closing price of Rs 320.00. Kilitch Drugs (India) Ltd share price trend:
- Last 1 Month: Kilitch Drugs (India) Ltd share price moved up by 100.98% on BSE.
- Last 3 Months: Kilitch Drugs (India) Ltd share price moved up by 74.38% on BSE.
- Last 12 Months: Kilitch Drugs (India) Ltd share price moved up by 40.76% on BSE.
- Last 3 Years: Kilitch Drugs (India) Ltd share price moved up by 154.14% on BSE.
2. How can I quickly analyse the performance of the Kilitch Drugs (India) Ltd stock?
The performance of the Kilitch Drugs (India) Ltd stock can be quickly analysed on the following metrics:
- The stock's PE is 25.31
- Price to book value ratio is 2.61
- The EPS (trailing 12 months) of the Kilitch Drugs (India) Ltd stock is Rs 12.13
3. What is the market cap of Kilitch Drugs (India) Ltd?
Kilitch Drugs (India) Ltd has a market capitalisation of Rs 494 crore.
4. What is Kilitch Drugs (India) Ltd's 52-week high/low share price?
The Kilitch Drugs (India) Ltd’s 52-week high share price is Rs 404.90 and 52-week low share price is Rs 271.30.
5. Is the Kilitch Drugs (India) Ltd profitable?
On a consolidated basis, Kilitch Drugs (India) Ltd reported a profit of Rs 5.61 crore on a total income of Rs 57.89 crore for the quarter ended 2024. For the year ended 2024, Kilitch Drugs (India) Ltd had posted a profit of Rs 13.58 crore on a total income of Rs 154.37 crore.
6. Which are Kilitch Drugs (India) Ltd’s peers in the Health care sector?
Kilitch Drugs (India) Ltd’s top 5 peers in the Health care sector are Medicamen Biotec, Ind-Swift Labs., Medico Remedies, Kilitch Drugs, Albert David, Megasoft, Jenburkt Pharma.
7. Who owns how much in Kilitch Drugs (India) Ltd?
Key changes to the Kilitch Drugs (India) Ltd shareholding are as follows:
- Promoter holding in Kilitch Drugs (India) Ltd has gone up to 68.25 per cent as of Dec 2022 from 68.25 per cent as of Mar 2022.
